NYSE
THQ Price Prediction, Tekla Healthcare Opportunities Fund ETF Technical Analysis
ETF market charts, price targets, analyst ratings and a financial calendar
Category @UnknownTHQ (Tekla Healthcare Opportunities Fund): Weekly Commentary
Forecasts, Signals and Predictions about THQ (Tekla Healthcare Opportunities Fund)
| Technical Analysis | # Of Indicators | Avg. Odds |
|---|---|---|
| Bullish trend | | |
| Bearish trend | | |
| Bearish trend | | |
| Bullish trend | |
| Fundamental Analysis | (1 - best, 100 - worst) |
|---|
THQ in -4.01% downward trend, falling for three consecutive days on January 20, 2022
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where THQ declined for three days, in
Current price $22.78 crossed the support line at $23.80 and is trading between $23.80 support and $22.67 support lines. Throughout the month of 12/17/21 - 01/20/22, the price experienced a -4% Downtrend. During the week of 01/12/22 - 01/20/22, the ETF fell -6%.
Technical Analysis, Outlook READ MORE...
Tekla Healthcare Opportunities Fund is a non-diversified closed-end fund in the United States. The fund's investment objective is to seek current income and long-term capital appreciation through investments in U.S. and non-U.S. companies in the healthcare industry (including equity securities, debt securities, and pooled investment vehicles). The fund invests primarily in securities of public and private companies.
The average weekly volume growth across all stocks in the Tekla Healthcare Opportunities Fund ETF was 4.46%. For the same stocks of the ETF, the average monthly volume growth was -9.68% and the average quarterly volume growth was 47.71%
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
General Information
| Category | Health |
| Address | 2 Liberty Square, 9 FloorBoston |
| Web | http://www.teklacap.com/index.html |
Select ETF attributes to show
| Net Assets | 955M |
| Yield | 0.18 |
| Fund Existence | 7 years ago |
| Total Expense Ratio | 1.44 |
| Turnover | 57.85 |
| Investment Style | N/A |
| Capitalization | N/A |
| Risk (Beta) | 0.78 |
| Manager Tenure | N/A |
| Administrative Fee | N/A |
| Annual Report Gross Expense Ratio | 1.44 |
| Assets in Top Ten Holdings | 425M |
| Average Credit Quality | N/A |
| Average Effective Duration | N/A |
| Average Effective Maturity | N/A |
| Fund of Funds | No |
| Fund Share Class Net Assets | 950M |
| Fund Type | ClosedEnd |
| Index Fund | No |
| Management Fee | 1.00 |
| Modified Duration | N/A |
| No Load Fund | Yes |
| Number of Long Holdings | 129.00 |
| Number of Net Holdings | 160.00 |
| Number of Short Holdings | 31.00 |
| Prospectus Acquired Expense Ratio | N/A |
| Weighting Top Ten Holdings | 42% |
| Gain YTD | -9.290 |
| Group | Alternative Funds |
| Category | Unknown |
| Total Expense Ratio | |
| Min. Initial Investment | 0.00 USD |
| Fund Existence | a few seconds ago |
| Turnover | |
| Front Load | |
| Net Assets | 0.00 USD |
| Manager Tenure |
| Group | Alternative Funds | |
| Category | Unknown | |
| Capitalization | 0.00 USD | |
| P/E Ratio | ||
| Total Cash | 0.00 USD | |
| Projected Growth | ||
| Total Debt | 0.00 USD | |
| Revenue | 0.00 USD | |
| Risk (Beta) | ||
| Dividend Yield | ||
| Total Cash/Share | ||
| Total Debt/Equity | ||
| Revenue/Share | 0.00USD | as % of share price |
| Group | Alternative Funds |
| Category | Unknown |
| Net Assets | 955.32m USD |
| Fund Existence | 7 years ago |
| Turnover | 57.85 |
| Capitalization | N/A |
| Yield | 0.17742 |
| Total Expense Ratio | 1.44 |
| Investment Style | N/A |
| Risk (Beta) | 0.78 |
| Group | Alternative Funds |
| Category | Unknown |
| Market Capitalization | 0.00 USD |
| Volume | 0.00 USD |
THQ:
TIME